Trials
Search / Trial NCT06431464

Tattoo Particles: Picosecond Laser Versus Nanosecond Laser

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · May 27, 2024

Trial Information

Current as of February 18, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating the effectiveness of two types of laser treatments—picosecond laser and nanosecond laser—for removing unwanted tattoos. The researchers want to understand how these lasers affect the tattoo ink particles and the surrounding skin tissue. By comparing the two methods, they hope to determine which one might be better for patients seeking tattoo removal.

To participate in this study, you need to be a healthy adult who is planning to remove an unwanted tattoo with laser treatment. Unfortunately, if you have previously treated your tattoo with a laser, are pregnant or breastfeeding, or have an open wound in the area to be treated, you won't be able to join. If you do qualify, you can expect to receive one of the laser treatments and help the researchers learn more about how these procedures work. This study is currently recruiting participants, so it's a great opportunity to contribute to our understanding of tattoo removal methods.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - healthy patients who plan a laser treatment of their unwanted tattoo/ tattoos at our department
  • Exclusion Criteria:
  • laser pretreatment of their tattoos to be treated
  • pregnancy, breast feeding
  • open wound on the area to be treated

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Hamburg, , Germany

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0